Lyell ImmunopharmaLYEL
那斯達克 · USD
14.37
+0.05
(+0.35%)
收盤 09/05 03:59 (UTC+8)
09/05 03:59 (UTC+8)
Lyell ImmunopharmaLYEL
14.37
+0.05
(+0.35%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- -76.92
- 333.33
- 161.54
- -67.65
- -36.36
- 14.29
- 87.50
- -60.00
- -66.67
- 100.00
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 4 | 2 | 6 | 15 | 8 | 7 | 11 | 34 | 13 | 3 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 4 | 2 | 6 | 15 | 8 | 7 | 11 | 34 | 13 | 3 |
營業費用 | 47,341 | 44,263 | 127,650 | 37,268 | 47,148 | 57,374 | 201,158 | 50,539 | 51,541 | 55,578 |
研發費用 | 39,524 | 36,604 | 52,199 | 28,172 | 34,857 | 43,447 | 48,668 | 39,500 | 40,261 | 43,174 |
推銷及管理費用 | 7,817 | 7,659 | 9,119 | 9,096 | 10,848 | 13,927 | 14,009 | 11,039 | 11,280 | 12,404 |
非經常性項目費用 | - | - | 66,332 | - | 1,443 | - | 138,481 | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -47,337 | -44,261 | -127,644 | -37,253 | -47,140 | -57,367 | -201,147 | -50,505 | -51,528 | -55,575 |
其他收入及費用 | 2,582 | 20,108 | -13,079 | -1,593 | 4,456 | 5,172 | 9,212 | 5,922 | 5,719 | -5,092 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -44,755 | -24,153 | -140,723 | -38,846 | -42,684 | -52,195 | -191,935 | -44,583 | -45,809 | -60,667 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -44,755 | -24,153 | -140,723 | -38,846 | -42,684 | -52,195 | -191,935 | -44,583 | -45,809 | -60,667 |
基本每股稅後盈餘(元) | -1.92 | -1.10 | -6.62 | -2.13 | -2.89 | -0.18 | -0.65 | -0.17 | -0.18 | -0.24 |
稀釋每股稅後盈餘(元) | -1.95 | -1.10 | -7.68 | -2.13 | -2.88 | -0.18 | -0.72 | -0.17 | -0.18 | -0.24 |
基本平均股數(千股) | 23364.00 | 21876.00 | 21251.00 | 18268.00 | 14793.00 | 295100.00 | 294875.00 | 256300.00 | 255400.00 | 254252.00 |
稀釋平均股數(千股) | 23364.00 | 21876.00 | 21251.00 | 18268.00 | 14793.00 | 295100.00 | 294875.00 | 256300.00 | 255400.00 | 254252.00 |
還原基本每股稅後盈餘(元) | -1.92 | -1.10 | -6.62 | -2.13 | -2.89 | -3.54 | -13.02 | -3.48 | -3.59 | -4.80 |
還原稀釋每股稅後盈餘(元) | -1.95 | -1.10 | -7.68 | -2.13 | -2.88 | -3.54 | -14.40 | -3.40 | -3.60 | -4.80 |
還原基本平均股數(千股) | 23,364 | 21,876 | 21,251 | 18,268 | 14,793 | 14,755 | 14,743 | 12,815 | 12,770 | 12,712 |
還原稀釋平均股數(千股) | 23,364 | 21,876 | 21,251 | 18,268 | 14,793 | 14,755 | 14,743 | 12,815 | 12,770 | 12,712 |
EBITDA(千元) | -43,355 | -22,707 | -139,386 | -37,289 | -40,714 | -50,479 | -189,874 | -43,490 | -44,670 | -60,010 |